Trial NCT02712905

View at ClinicalTrials.gov 
Org. Study IDs: INCB 59872-101

Last trial update was posted on 2023-06-12

MeSH Interventions

Azacitidine Nivolumab Tretinoin

MeSH Conditions

Hematologic Neoplasms Neoplasms

Other Conditions

Solid Tumors and Hematologic Malignancy

Stopping Reasons

Strategic Business Decision

Limitations And Caveats

The study was terminated by the sponsor due to a strategic business decision.

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID